Virbac SA (VRBCF)

USD 339.23

(0.0%)

Eps Summary of Virbac SA

Virbac SA's latest annual eps in 2023 was 14.38 EUR , down -0.28% from previous year.
Virbac SA's latest quarterly eps in 2024 Q2 was 5.65 EUR , down 0.0% from previous quarter.
Virbac SA reported an annual eps of 14.44 EUR in 2022, up 7.76% from previous year.
Virbac SA reported an annual eps of 13.40 EUR in 2021, down -16.87% from previous year.
Virbac SA reported a quarterly eps of 5.65 EUR for 2024 Q2, down 0.0% from previous quarter.
Virbac SA reported a quarterly eps of N/A for 2023 FY, down -0.28% from previous quarter.

Annual Eps Chart of Virbac SA (2023 - 2002)

Historical Annual Eps of Virbac SA (2023 - 2002)

Year	Eps	Eps Growth
2023	14.38 EUR	-0.28%
2022	14.44 EUR	7.76%
2021	13.40 EUR	-16.87%
2020	16.12 EUR	163.83%
2019	6.11 EUR	155.65%
2018	2.39 EUR	870.97%
2017	-0.31 EUR	-107.54%
2016	4.11 EUR	266.96%
2015	1.12 EUR	-85.15%
2014	7.54 EUR	5.01%
2013	7.18 EUR	-9.23%
2012	7.91 EUR	15.81%
2011	6.83 EUR	-6.69%
2010	7.32 EUR	63.39%
2009	4.48 EUR	9.0%
2008	4.11 EUR	14.17%
2007	3.60 EUR	23.71%
2006	2.91 EUR	24.89%
2005	2.33 EUR	15.92%
2004	2.01 EUR	-36.39%
2003	3.16 EUR	-30.85%
2002	4.57 EUR	0.0%

Year	Eps	Eps Growth
2024 Q1	5.65 EUR	103.97%
2024 Q2	5.65 EUR	0.0%
2023 FY	- EUR	-0.28%
2023 Q2	8.89 EUR	101.13%
2023 Q3	2.77 EUR	-68.84%
2023 Q4	2.77 EUR	0.0%
2023 Q1	4.42 EUR	-15.97%
2022 Q1	4.59 EUR	-3.97%
2022 Q2	9.18 EUR	100.0%
2022 Q3	2.63 EUR	-71.35%
2022 Q4	5.26 EUR	100.0%
2022 FY	- EUR	7.76%
2021 Q4	4.78 EUR	96.71%
2021 FY	- EUR	-16.87%
2021 Q2	8.61 EUR	102.11%
2021 Q1	4.26 EUR	-60.19%
2021 Q3	2.43 EUR	-71.78%
2020 FY	- EUR	163.83%
2020 Q2	5.59 EUR	100.36%
2020 Q1	2.79 EUR	-6.38%
2020 Q4	10.70 EUR	103.42%
2020 Q3	5.26 EUR	-5.9%
2019 Q2	1.57 EUR	0.0%
2019 Q4	2.98 EUR	100.0%
2019 FY	- EUR	155.65%
2019 Q3	1.49 EUR	-5.1%
2019 Q1	1.57 EUR	241.3%
2018 Q3	0.46 EUR	-36.99%
2018 FY	- EUR	870.97%
2018 Q2	0.73 EUR	0.0%
2018 Q1	0.73 EUR	174.49%
2018 Q4	0.46 EUR	0.0%
2017 Q3	-0.98 EUR	-218.07%
2017 Q2	0.83 EUR	0.0%
2017 Q4	-0.98 EUR	0.0%
2017 FY	- EUR	-107.54%
2017 Q1	0.83 EUR	-35.16%
2016 Q4	1.28 EUR	0.0%
2016 Q1	0.78 EUR	0.0%
2016 FY	- EUR	266.96%
2016 Q3	1.28 EUR	64.1%
2016 Q2	0.78 EUR	0.0%
2015 Q2	-0.23 EUR	0.0%
2015 FY	- EUR	-85.15%
2015 Q4	0.78 EUR	0.0%
2015 Q3	0.78 EUR	439.13%
2015 Q1	-0.23 EUR	-110.85%
2014 Q1	1.65 EUR	0.0%
2014 FY	- EUR	5.01%
2014 Q3	2.12 EUR	28.48%
2014 Q4	2.12 EUR	0.0%
2014 Q2	1.65 EUR	0.0%
2013 Q1	1.93 EUR	0.0%
2013 FY	- EUR	-9.23%
2013 Q3	1.65 EUR	-14.51%
2013 Q2	1.93 EUR	0.0%
2013 Q4	1.65 EUR	0.0%
2012 FY	- EUR	15.81%
2011 FY	- EUR	-6.69%
2010 FY	- EUR	63.39%
2009 FY	- EUR	9.0%
2008 FY	- EUR	14.17%
2007 FY	- EUR	23.71%
2006 FY	- EUR	24.89%
2005 FY	- EUR	15.92%
2004 FY	- EUR	-36.39%
2003 FY	- EUR	-30.85%
2002 FY	- EUR	0.0%

Peer Eps Comparison of Virbac SA

Name	Eps	Eps Difference
AstraZeneca PLC	3.84 USD	-274.479%
Bristol-Myers Squibb Company PFD CONV 2	3.88 USD	-270.619%
CSPC Pharmaceutical Group Limited	0.07 USD	-20442.857%
Clarus Therapeutics Holdings, Inc.	-8.04 USD	278.856%
Novartis AG	7.63 USD	-88.467%
PT Kalbe Farma Tbk.	0.00 USD	-368617.949%